The diagnosis and management of parasellar tumours of the pituitary

Endocrine-Related Cancer

Volumn 15, Issue 4, 2008, Pages 885-903

  Kaltsas, Gregory A ^a   Evanson, Jane ^b   Chrisoulidou, Alexandra ^c   Grossman, Ashley B ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c THEAGENIO CANCER HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; CISPLATIN; CLADRIBINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; PLATINUM DERIVATIVE; STEROID; VINBLASTINE;

CANCER GRADING; CHONDROSARCOMA; CHORDOMA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CRANIOPHARYNGIOMA; CRANIOTOMY; CYTOREDUCTIVE SURGERY; DIAGNOSTIC ACCURACY; DRUG MEGADOSE; ENDOCRINE SYSTEM EXAMINATION; EPENDYMOMA; EPIDERMOID TUMOR; EVIDENCE BASED MEDICINE; FOLLOW UP; GERM CELL TUMOR; GLIOMA; GRANULAR CELL TUMOR; HAMARTOMA; HEMANGIOPERICYTOMA; HIGH RISK PATIENT; HISTIOCYTOSIS X; HISTOPATHOLOGY; HUMAN; HYPOPHYSIS DISEASE; HYPOPHYSIS PARASELLAR METASTASIS; HYPOPHYSIS PARASELLAR TUMOR; HYPOPHYSIS TUMOR; HYPOTHALAMUS TUMOR; IMAGE ANALYSIS; LIPOMA; LYMPHOMA; MALIGNANT TRANSFORMATION; MEDICAL DECISION MAKING; MENINGIOMA; NEURILEMOMA; NEURINOMA; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; PRIMARY PARASELLAR LYMPHOMA; PROGNOSIS; RATHKE CLEFT CYST; REVIEW; SURGICAL TECHNIQUE;

ADENOMA; HUMANS; PITUITARY NEOPLASMS;

EID: 58249102304     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-08-0170     Document Type: Review

References (99)

1. Aghi M & Barker FG 2006 Benign adult brain tumors: an evidence-based medicine review. Progress in Neurological Surgery 19 80-96.
2. Allan CA, Kaltsas G, Evanson J, Geddes J, Lowe DG, Plowman PN & Grossman AB 2001 Pituitary chondrosarcoma: an unusual cause of a sellar mass presenting as a pituitary adenoma. Journal of Clinical Endocrinology and Metabolism 86 386-391.
3. Allen JC 1987 Management of primary intracranial germ cell tumors of childhood. Pediatric Neuroscience 13 152-157.
4. Allen JC, Kim JH & Packer RJ 1987 Neoadjuvant chemotherapy for newly diagnosed germ-cell tumors of the central nervous system. Journal of Neurosurgery 67 65-70.
5. Arceci RJ 1999 The histiocytoses: the fall of the Tower of Babel. European Journal of Cancer 35 747-767.
6. Arico M, Girschikofsky M, Genereau T, Klersy C, McClain K, Grois N, Emile JF, Lukina E, De Juli E & Danesino C 2003 Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. European Journal of Cancer 39 2341-2348.
7. Balmaceda C, Heller G, Rosenblum M, Diez B, Villablanca JG, Kellie S, Maher P, Vlamis V, Walker RW, Leibel S et al. 1996 Chemotherapy without irradiation - a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study. Journal of Clinical Oncology 14 2908-2915.
8. Baskin DS & Wilson CB 1986 Surgical management of craniopharyngiomas. A review of 74 cases. Journal of Neurosurgery 65 22-27.
9. Black KL & Pikul BK 1999 Gliomas-past, present, and future. Clinical Neurosurgery 45 160-163.
10. Boardman JF, Rothfus WE & Dulai HS 2008 Lesions and pseudolesions; of the cavernous sinus and petrous apex. Otolaryngologic Clinics of North America 41 195-213.
11. Boari N, Losa M, Mortini P, Snider S, Terreni MR & Giovanelli M 2006 Intrasellar paraganglioma: a case report and review of the literature. Acta Neurochirurgica 148 1311-1314.
12. Brada M & Cruickshank G 1999 Radiosurgery for brain tumours. BMJ 318 411-412.
13. Bruna J, Brell M, Ferrer I, Gimenez-Bonafe P & Tortosa A 2007 Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma. Neuropathology 27 114-120.
14. Buhring U, Herrlinger U, Krings T, Thiex R, Weller M & Kuker W 2001 MRI features of primary central nervous system lymphomas at presentation. Neurology 57 393-396.
15. Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F & Bruner JM 1998 The descriptive epidemiology of craniopharyngioma. Journal of Neurosurgery 89 547-551.
16. Calaminus G, Bamberg M, Harms D, Jurgens H, Kortmann RD, Sorensen N, Wiestler OD & Gobel U 2005 AFP/beta-HCG secreting CNS germ cell tumors: long-term outcome with respect to initial symptoms and primary tumor resection. Results of the cooperative trial MAKEI 89. Neuropediatrics 36 71-77.
17. Chiang MF, Brock M & Patt S 1990 Pituitary metastases. Neurochirurgia 33 127-131.
18. Chong BW & Newton TH 1993 Hypothalamic and pituitary pathology. Radiologic Clinics of North America 31 1147-1153.
19. Cohen-Gadol AA, Pichelmann MA, Link MJ, Scheithauer BW, Krecke KN, Young WF Jr, Hardy J & Giannini C 2003 Granular cell tumor of the sellar and suprasellar region: clinicopathologic study of 11 cases and literature review. Mayo Clinic Proceedings 78 567-573.
20. Coke CC, Corn BW, Werner-Wasik M, Xie Y & Curran WJ Jr 1998 Atypical and malignant meningiomas: an outcome report of seventeen cases. Journal of Neuro-Oncology 39 65-70.
21. Cone L, Srinivasan M & Romanul FC 1990 Granular cell tumor (choristoma) of the neurohypophysis: two cases and a review of the literature. American Journal of Neuroradiology 11 403-406.
22. Corn BW, Dolinskas C, Scott C, Donahue B, Schultz C, Nelson DF & Fisher B 2000 Strong correlation between imaging response and survival among patients with primary central nervous system lymphoma: a secondary analysis of RTOG studies 83-15 and 88-06. International Journal of Radiation Oncology, Biology, Physics 47 299-303.
23. Couldwell WT, Weiss MH, Rabb C, Liu JK, Apfelbaum RI & Fukushima T 2004 Variations on the standard transsphenoidal approach to the sellar region, with emphasis on the extended approaches and parasellar approaches: surgical experience in 105 cases. Neurosurgery 55 539-547.
24. Day JD 2003 Surgical approaches to suprasellar and parasellar tumors. Neurosurgery Clinics of North America 14 109-122.
25. Fine HA & Mayer RJ 1993 Primary central nervous system lymphoma. Annals of Internal Medicine 119 1093-1104.
26. FitzPatrick M, Tartaglino LM, Hollander MD, Zimmerman RA & Flanders AE 1999 Imaging of sellar and parasellar pathology. Radiologic Clinics of North America 37 101-121.
27. Freda PU & Post KD 1999 Differential diagnosis of sellar masses. Endocrinology and Metabolism Clinics of North America 28 81-117.
28. Freda PU, Wardlaw SL & Post KD 1996 Unusual causes of sellar/ parasellar masses in a large transsphenoidal surgical series. Journal of Clinical Endocrinology and Metabolism 81 3455-3459.
29. Freeman JL, Coleman LT, Wellard RM, Kean MJ, Rosenfeld JV, Jackson GD, Berkovic SF & Harvey AS 2004 MR imaging and spectroscopic study of epileptogenic hypothalamic hamartomas: analysis of 72 cases. American Journal of Neuroradiology 25 450-462.
30. Frighetto L, De Salles AA, Behnke E, Smith ZA & Chute D 2003 Image-guided frameless stereotactic biopsy sampling of parasellar lesions. Technical note. Journal of Neurosurgery 98 920-925.
31. Giller CA & Berger BD 2005 New frontiers in radiosurgery for the brain and body. Proceedings 18 311-319.
32. Giller CA, Berger BD, Pistenmaa DA, Sklar F, Weprin B, Shapiro K, Winick N, Mulne AF, Delp JL, Gilio JP et al. 2005 Robotically guided radiosurgery for children. Pediatric Blood & Cancer 45 304-310.
33. Glezer A, Paraiba DB & Bronstein MD 2008 Rare sellar lesions. Endocrinology and Metabolism Clinics of North America 37 195-211.
34. Gobel U, Schneider DT, Calaminus G, Jurgens H, Spaar HJ, Sternschulte W, Waag K & Harms D 2001 Multimodal treatment of malignant sacrococcygeal germ cell tumors: a prospective analysis of 66 patients of the German cooperative protocols MAKEI 83/86 and 89. Journal of Clinical Oncology 19 1943-1950.
35. Guillamo JS, Doz F & Delattre JY 2001 Brain stem gliomas. Current Opinion in Neurology 14 711-715.
36. Hald JK, Eldevik OP, Brunberg JA & Chandler WF 1994 Craniopharyngiomas - the utility of contrast medium enhancement for MR imaging at 1.5 T. Acta Radiologica 35 520-525.
37. Hartmann C, Bostrom J & Simon M 2006 Diagnostic and molecular pathology of meningiomas. Expert Review of Neurotherapeutics 6 1671-1683.
38. Hoang-Xuan K, Capelle L, Kujas M, Taillibert S, Duffau H, Lejeune J, Polivka M, Criniere E, Marie Y, Mokhtari K et al. 2004 Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. Journal of Clinical Oncology 22 3133-3138.
39. Honegger J, Buchfelder M, Fahlbusch R, Daubler B & Dorr HG 1992 Transsphenoidal microsurgery for craniopharyngioma. Surgical Neurology 37 189-196.
40. Ito I, Ishida T, Hashimoto T, Arita M, Osawa M, Yokota T & Ishimori T 2001 Hypopituitarism due to pituitary metastasis of lung cancer: case of a 21-year-old man. Internal Medicine 40 414-417.
41. Jagannathan J, Kanter AS, Sheehan JP, Jane JA Jr & Laws ER Jr 2007 Benign brain tumors: sellar/parasellar tumors. Neurologic Clinics 25 1231-1249.
42. Jalali R, Srinivas C, Nadkarni TD & Rajasekharan P 2008 Suprasellar haemangiopericytoma - challenges in diagnosis and treatment. Acta Neurochirurgica 150 67-71.
43. Janmohamed S, Grossman AB, Metcalfe K, Lowe DG, Wood DF, Chew SL, Monson JP, Besser GM & Plowman PN 2002 Suprasellar germ cell tumours: specific problems and the evolution of optimal management with a combined chemoradiotherapy regimen. Clinical Endocrinology 57 487-500.
44. Jennings MT, Gelman R & Hochberg F 1985 Intracranial germ-cell tumors: natural history and pathogenesis. Journal of Neurosurgery 63 155-167.
45. Judge DM, Kulin HE, Page R, Santen R & Trapukdi S 1977 Hypothalamic hamartoma: a source of luteinizing-hormone-releasing factor in precocious puberty. New England Journal of Medicine 296 7-10.
46. Kaltsas GA, Powles TB, Evanson J, Plowman PN, Drinkwater JE, Jenkins PJ, Monson JP, Besser GM & Grossman AB 2000 Hypothalamo-pituitary abnormalities in adult patients with Langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. Journal of Clinical Endocrinology and Metabolism 85 1370-1376.
47. Karavitaki N, Cudlip S, Adams CB & Wass JA 2006 Craniopharyngiomas. Endocrine Reviews 27 371-397.
48. Karim M, Sylvia A, Fred G & Patrick S 2006 Ependymoma of the pituitary fossa. Case report and review of the literature. Journal of Neurosurgery 105 616-620.
49. Kitange GJ, Templeton KL & Jenkins RB 2003 Recent advances in the molecular genetics of primary gliomas. Current Opinion in Oncology 15 197-203.
50. Kleihues P, Burger PC & Scheithauer BW 1993 The new WHO classification of brain tumours. Brain Pathology 3 255-268.
51. Ko KW, Nam DH, Kong DS, Lee JI, Park K & Kim JH 2007 Relationship between malignant subtypes of meningioma and clinical outcome. Journal of Clinical Neuroscience 14 747-753.
52. Komninos J, Vlassopoulou V, Protopapa D, Korfias S, Kontogeorgos G, Sakas DE & Thalassinos NC 2004 Tumors metastatic to the pituitary gland: case report and literature review. Journal of Clinical Endocrinology and Metabolism 89 574-580.
53. Korten AG, ter Berg HJ, Spincemaille GH, van der Laan RT & Van de Wel AM 1998 Intracranial chondrosarcoma: review of the literature and report of 15 cases. Journal of Neurology, Neurosurgery, and Psychiatry 65 88-92.
54. Kunanandam V & Gooding MR 1995 Parasellar chondrosarcoma: total excision improves prognosis. British Journal of Neurosurgery 9 87-91.
55. Laigle-Donadey F, Taillibert S, Martin-Duverneuil N, Hildebrand J & Delattre JY 2005 Skull-base metastases. Journal of Neuro-Oncology 75 63-69.
56. Lamberts SW, de Herder WW & van der Lely AJ 1998 Pituitary insufficiency. Lancet 352 127-134.
57. Lefranc F, Chevalier C, Vinchon M, Dhellemmes P, Schuring MP, Kaltner H, Brotchi J, Ruchoux MM, Gabius HJ, Salmon I et al. 2003 Characterization of the levels of expression of retinoic acid receptors, galectin-3, macrophage migration inhibiting factor, and p53 in 51 adamantinomatous craniopharyngiomas. Journal of Neurosurgery 98 145-153.
58. Legido A, Packer RJ, Sutton LN, D'Angio G, Rorke LB, Bruce DA & Schut L 1989 Suprasellar germinomas in childhood. A re appraisal. Cancer 63 340-344.
59. Liu JK, Sayama C, Chin SS & Couldwell WT 2007 Extranodal NK/T-cell lymphoma presenting as a pituitary mass. Case report and review of the literature. Journal of Neurosurgery 107 660-665.
60. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW & Kleihues P 2007 The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathologica 114 97-109.
61. Maira G, Anile C, Rossi GF & Colosimo C 1995 Surgical treatment of craniopharyngiomas: an evaluation of the transsphenoidal and pterional approaches. Neurosurgery 36 715-724.
62. Makras P, Alexandraki KI, Chrousos GP, Grossman AB & Kaltsas GA 2007 Endocrine manifestations in Langerhans cell histiocytosis. Trends in Endocrinology and Metabolism 18 252-257.
63. Matsutani M, Sano K, Takakura K, Fujimaki T, Nakamura O, Funata N & Seto T 1997 Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. Journal of Neurosurgery 86 446-455.
64. Matthay KK, Brisse H, Couanet D, Couturier J, Benard J, Mosscri V, Edeline V, Lumbroso J, Valteau-Couanet D & Michon J 2003 Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients. Cancer 98 155-165.
65. Megan Ogilvie C, Payne S, Evanson J, Lister TA & Grossman AB 2005 Lymphoma metastasizing to the pituitary: an unusual presentation of a treatable disease. Pituitary 8 139-146.
66. Mena H, Ribas JL, Pezeshkpour GH, Cowan DN & Parisi JE 1991 Hemangiopericytoma of the central nervous system: a review of 94 cases. Human Pathology 22 84-91.
67. Meyers SP, Hirsch WL Jr, Curtin HD, Barnes L, Sekhar LN & Sen C 1992 Chondrosarcomas of the skull base: MR imaging features. Radiologica 184 103-108.
68. Morita A, Meyer FB & Laws ER Jr 1998 Symptomatic pituitary metastases. Journal of Neurosurgery 89 69-73.
69. Mukherjee JJ, Islam N, Kaltsas G, Lowe DG, Charlsworth M, Afshar F, Trainer PJ, Monson JP, Besser GM & Grossman AB 1997 Clinical, radiological and pathological features of patients with Rathke's cleft cysts: tumors that may recur. Journal of Clinical Endocrinology and Metabolism 82 2357-2362.
70. Nakane Y, Natsume A, Wakabayashi T, Oi S, Ito M, Inao S, Saito K & Yoshida J 2007 Malignant transformation-related genes in meningiomas: allelic loss on 1p36 and methylation status of p73 and RASSFIA. Journal of Neurosurgery 107 399-404.
71. Nelson GA, Bastian FO, Schlitt M & White RL 1988 Malignant transformation in craniopharyngioma. Neurosurgery 22 427-429.
72. Ohba S, Yoshida K, Hirose Y, Ikeda E & Kawase T 2008 A supratentorial primitive neuroectodermal tumor in an adult: a case report and review of the literature. Journal of Neuro-Oncology 86 217-224.
73. Osuka S, Tsuboi K, Takano S, Ishikawa E, Matsushita A, Tokuuye K, Akine Y & Matsumura A 2007 Long-term outcome of patients with intracranial germinoma. Journal of Neuro-Oncology 83 71-79.
74. Packer RJ 2000 Chemotherapy: low-grade gliomas of the hypothalamus and thalamus. Pediatric Neurosurgery 32 259-263.
75. Packer RJ, Cohen BH & Cooney K 2000 Intracranial germ cell tumors. Oncologist 5 312-320.
76. Perks JR, Jalali R, Cosgrove VP, Adams EJ, Shepherd SF, Warrington AP & Brada M 1999 Optimization of stereotactically-guided conformal treatment planning of sellar and parasellar tumors, based on normal brain dose volume histograms. International Journal of Radiation Oncology, Biology, Physics 45 507-513.
77. Petito CK, DeGirolami U & Earle KM 1976 Craniopharyngiomas: a clinical and pathological review. Cancer 37 1944-1952.
78. Pusey E, Kortman KE, Flannigan BD, Tsuruda J & Bradley WG 1987 MR of craniopharyngiomas: tumor delineation and characterization. American Journal of Roentgenology 149 383-388.
79. Rajan B, Ashley S, Thomas DG, Marsh H, Britton J & Brada M 1997 Craniopharyngioma: improving outcome by early recognition and treatment of acute complications. International Journal of Radiation Oncology, Biology, Physics 37 517-521.
80. Recinos PF, Sciubba DM & Jallo GI 2007 Brainstem tumors: where are we today? Pediatric Neurosurgery 43 192-201.
81. Rennert J & Doerfler A 2007 Imaging of sellar and parasellar lesions. Clinical Neurology and Neurosurgery 109 111-124.
82. La Rocca RV, Morgan KW, Paris K & Baeker TR 1999 Recurrent chondrosarcoma of the cranial base: a durable response to ifosfamide-doxorubicin chemotherapy. Journal of Neuro-Oncology 41 281-283.
83. Rosenberg AE, Brown GA, Bhan AK & Lee JM 1994 Chondroid chordoma - a variant of chordoma. A morphologic and immunohistochemical study. American Journal of Clinical Pathology 101 36-41.
84. Ruelle A, Palladino M & Andrioli GC 1992 Pituitary metastases as presenting lesions of malignancy. Journal of Neurosurgical Sciences 36 51-54.
85. Ruscalleda J 2005 Imaging of parasellar lesions. European Radiology 15 549-559.
86. Salisbury JR & Isaacson PG 1986 Distinguishing chordoma from chondrosarcoma. by immunohistochemical techniques. Journal of Pathology 148 251-252.
87. Samandouras G, Kerr RS & Milford CA 2005 Minimally invasive biopsy of parasellar lesions: safety and clinical applications of the endoscopic, transnasal approach. British Journal of Neurosurgery 19 338-344.
88. Sioutos P, Yen V & Arbit E 1996 Pituitary gland metastases. Annals of Surgical Oncology 3 94-99.
89. Smith JK 2005 Parasellar tumors: suprasellar and cavernous sinuses. Topics in Magnetic Resonance Imaging 16 307-315.
90. Steel TR, Dailey AT, Born D, Berger MS & Mayberg MR 1993 Paragangliomas of the sellar region: report of two cases. Neurosurgery 32 844-847.
91. Stout AP & Murray MR 1942 Hemangiopericytoma: a vascular tumour featuring Zimmermann's pericytes. Annals of Surgery 116 26-33.
92. Suh JH & Gupta N 2006 Role of radiation therapy and radiosurgery in the management of craniopharyngiomas. Neurosurgery Clinics of North America 17 143-148.
93. Tarbell NJ, Barnes P, Scott RM, Goumnerova L, Pomeroy SL, Black PM, Sallan SE, Billett A, LaVally B, Helmus A et al. 1994 Advances in radiation therapy for craniopharyngiomas. Pediatric Neurosurgery 21 (Supplement 1) 101-107.
94. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC & Stewart PM 2001 Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357 425-431.
95. Vidal S, Kovacs K, Lloyd RV, Meyer FB & Scheithauer BW 2002 Angiogenesis in patients with craniopharyngiomas: correlation with treatment and outcome. Cancer 94 738-745.
96. Yokota M, Tani E, Maeda Y, Morimura T, Kakudo K & Uematsu K 1985 Acromegaly associated with suprasellar and pulmonary hemangiopericytomas. Case report. Journal of Neurosurgery 62 767-771.
97. Young SC, Grossman RI, Goldberg HI, Spagnoli MV, Hackney DB, Zimmerman RA & Bilaniuk LT 1988 MR of vascular encasement in parasellar masses: comparison with angiography and CT. American Journal of Neuroradiology 9 35-38.
98. Zee CS, Go JL, Kim PE, Mitchell D & Ahmadi J 2003 Imaging of the pituitary and parasellar region. Neurosurgery Clinics of North America 14 55-80.
99. Zhang YQ, Wang CC & Ma ZY 2002 Pediatric craniopharyngiomas: clinicomorphological study of 189 cases. Pediatric Neurosurgery 36 80-84.